Home
About
Overview
Sharing Data
ORCID
Help
History (3)
"Medical Benefit" and Therapeutic Misconception: The Ethical Conundrum of Phase 1 Pediatric Oncology Research.
Personalized medicine: building the GPS to take us there.
Xanthine oxidase mediates hypoxia-inducible factor-2a degradation by intermittent hypoxia.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Personalized medicine: building the GPS to take us there.
Personalized medicine: building the GPS to take us there. Clin Pharmacol Ther. 2007 Mar; 81(3):321-2.
View in:
PubMed
subject areas
Drug Therapy
Drug-Related Side Effects and Adverse Reactions
Genotype
Humans
Medicine
National Institutes of Health (U.S.)
Pharmacogenetics
United States
authors with profiles
Mark Ratain